BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 70 filers reported holding BIODELIVERY SCIENCES INTL IN in Q2 2018. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $743,000 | -14.3% | 190,100 | -7.9% | 0.00% | 0.0% |
| Q4 2020 | $867,000 | +10.4% | 206,501 | -1.9% | 0.00% | 0.0% |
| Q3 2020 | $785,000 | -11.6% | 210,501 | +3.4% | 0.00% | 0.0% |
| Q2 2020 | $888,000 | +23.0% | 203,601 | +6.8% | 0.00% | 0.0% |
| Q1 2020 | $722,000 | -59.3% | 190,633 | -32.1% | 0.00% | -50.0% |
| Q4 2019 | $1,775,000 | +43.3% | 280,833 | -4.6% | 0.00% | +100.0% |
| Q3 2019 | $1,239,000 | +0.4% | 294,230 | +10.9% | 0.00% | 0.0% |
| Q2 2019 | $1,234,000 | -10.3% | 265,430 | +2.3% | 0.00% | -50.0% |
| Q1 2019 | $1,375,000 | +43.2% | 259,400 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $960,000 | +32.2% | 259,400 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $726,000 | -5.1% | 259,400 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $765,000 | +31.0% | 259,400 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $584,000 | -23.7% | 259,400 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $765,000 | 0.0% | 259,400 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $765,000 | +5.4% | 259,400 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $726,000 | +47.3% | 259,400 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $493,000 | +7.2% | 259,400 | -1.3% | 0.00% | 0.0% |
| Q4 2016 | $460,000 | +95.7% | 262,900 | +202.5% | 0.00% | – |
| Q3 2016 | $235,000 | +7.3% | 86,900 | -6.5% | 0.00% | – |
| Q2 2016 | $219,000 | -29.1% | 92,900 | -3.0% | 0.00% | – |
| Q1 2016 | $309,000 | -36.6% | 95,800 | -5.8% | 0.00% | -100.0% |
| Q4 2015 | $487,000 | -13.8% | 101,700 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $565,000 | -32.5% | 101,700 | -3.3% | 0.00% | 0.0% |
| Q2 2015 | $837,000 | -58.9% | 105,200 | -28.3% | 0.00% | -66.7% |
| Q1 2015 | $2,037,000 | 0.0% | 146,630 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $2,037,000 | -14.6% | 146,630 | +5.1% | 0.00% | 0.0% |
| Q3 2014 | $2,385,000 | +87.8% | 139,565 | +32.7% | 0.00% | +50.0% |
| Q2 2014 | $1,270,000 | +55.3% | 105,200 | 0.0% | 0.00% | +100.0% |
| Q1 2014 | $818,000 | +31.7% | 105,200 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $621,000 | +7.8% | 105,200 | -0.8% | 0.00% | 0.0% |
| Q3 2013 | $576,000 | +33.6% | 106,100 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $431,000 | – | 106,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,595,855 | $10,929,000 | 10.61% |
| Broadfin Capital, LLC | 4,300,066 | $18,103,000 | 3.35% |
| 1492 Capital Management LLC | 778,483 | $3,277,000 | 3.20% |
| Avoro Capital Advisors LLC | 7,424,867 | $31,259,000 | 1.30% |
| Rubric Capital Management LP | 2,590,288 | $10,905,000 | 1.00% |
| Eversept Partners, LP | 708,020 | $2,980,764 | 0.92% |
| KNOTT DAVID M | 517,507 | $2,179,000 | 0.92% |
| Nantahala Capital Management | 4,846,167 | $20,402,000 | 0.76% |
| Grandeur Peak Global Advisors, LLC | 1,180,075 | $4,968,000 | 0.54% |
| EMERALD ADVISERS, LLC | 2,084,685 | $8,777,000 | 0.41% |